AsurDx™ Reticuloendotheliosis Virus (REV) Antibody Test Kit
The AsurDxTM Reticuloendotheliosis Virus(REV) Antibody Test Kitis designed for the detection of chicken antibodies specific to reticuloendotheliosis virus (REV).
- Detects REV antibodies of the IgG in serum/plasma;
- Procedures last less than 75 minutes;
- Provides a simple, rapid, sensitive and cost-effective enzyme-based immunoassay (ELISA) screening method
*Availability/Distribution: Product is designed and developed by BioStone US Texas headquarter and manufactured/assembled by BioStone oversea subsidiaries or partners. Currently, the product is only available outside of the USA. Regulatory requirements vary by oversea countries; the product may not be available in your geographic area.
|Coated Antigen||REV antigen-coated Plate|
|Incubation Time||75 minutes|
|Storage||At least 12 months|
|Specificity||REV serogroup-specific chicken antibodies|
|Plates||2 plates||5 plates|
|Plate Format||12 X 8-well strips||12 X 8-well strips|
Reticuloendotheliosis virus (REV) is a retrovirus that is morphologically similar to, but genetically distinct from, the avian leukosis/sarcoma viruses. Reticuloendotheliosis designates a group of pathologic syndromes caused by REV group of avian retroviruses. The disease syndromes associated with REV include a runting disease syndrome, chronic neoplasia of lymphoid and other tissues, and acute reticulum cell neoplasia. The clinical findings for runting syndrome include weight loss, paleness, occasional paralysis, and abnormal feathering. Death from acute or chronic neoplasia is preceded by depression and occasionally by some of the same clinical changes described for the runting syndrome.